Edition:
India

Aphria Inc (APH.TO)

APH.TO on Toronto Stock Exchange

14.06CAD
16 Feb 2018
Change (% chg)

$-0.82 (-5.51%)
Prev Close
$14.88
Open
$14.26
Day's High
$14.66
Day's Low
$13.77
Volume
2,524,796
Avg. Vol
4,607,889
52-wk High
$24.75
52-wk Low
$4.55

Chart for

About

Aphria Inc., formerly Black Sparrow Capital Corp., is a Canada-based company, which is engaged in producing and selling medical marijuana through retail sales and wholesale channels. The Company's retail sales are primarily sold through the Company's online store, as well as telephone orders. Its wholesale shipments are sold to... (more)

Overall

Beta: --
Market Cap(Mil.): $1,034.72
Shares Outstanding(Mil.): 138.89
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.64
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Aphria Signs LoI With SAQ To Supply Up To 12,000 KG Of Cannabis Annually

* APHRIA SIGNS LETTER OF INTENT WITH SAQ TO SUPPLY UP TO 12,000 KG OF CANNABIS ANNUALLY TO QUEBEC MARKET Source text for Eikon: Further company coverage:

14 Feb 2018

BRIEF-Aphria Says Divested About 26.7 Mln Shares In Liberty, At $1.25 Per Share

* APHRIA BEGINS TO DIVEST OF ITS EQUITY INVESTMENT IN PASSIVE US ASSETS

05 Feb 2018

Pot company Aphria to sell stake in U.S. cannabis grower

Canadian marijuana company Aphria Inc said on Friday it agreed to sell its minority stake in U.S.-based Copperstate Farms to Liberty Health Sciences Inc for C$20 million ($16.14 million).

02 Feb 2018

BRIEF-Aphria And Liberty Health Announce Sale Of Aphria's Investment In Copperstate Farms To Liberty

* APHRIA AND LIBERTY HEALTH SCIENCES ANNOUNCE DEFINITIVE AGREEMENT FOR SALE OF APHRIA'S INVESTMENT IN COPPERSTATE FARMS TO LIBERTY

02 Feb 2018

BRIEF-Aphria Considers Strategic Alternatives For Its U.S. Cannabis Interests

* APHRIA CONSIDERS STRATEGIC ALTERNATIVES FOR ITS US CANNABIS INTERESTS

01 Feb 2018

Canada cannabis firm Aphria mulls sale of U.S. unit

Feb 1 Canadian cannabis company Aphria Inc said on Thursday it was exploring strategic alternatives, including a sale, for its U.S. business, amid tightening enforcement of federal cannabis laws in the country. Earlier this year, the U.S. Department of Justice revoked an Obama administration policy that discouraged federal prosecutors from pursuing marijuana-related crimes in states that had legalized the drug.

01 Feb 2018

Canada's Aphria to buy rival Nuuvera for $670 million

Canadian cannabis company Aphria Inc said Monday it would buy rival Nuuvera Inc for C$826 million ($670 million), ahead of a raft of medical cannabis approvals around the world over the coming years.

29 Jan 2018

UPDATE 2-Canada's Aphria to buy rival Nuuvera for $670 million

Jan 29 Canadian cannabis company Aphria Inc said Monday it would buy rival Nuuvera Inc for C$826 million ($670 million), ahead of a raft of medical cannabis approvals around the world over the coming years.

29 Jan 2018

UPDATE 1- Weed company Aphria to buy rival Nuuvera for C$826 mln

Jan 29 Canadian cannabis company Aphria Inc on Monday said it would buy rival Nuuvera Inc for C$826 million ($670 million) to expand globally, ahead of Canada's proposed legalisation of recreational weed by mid 2018.

29 Jan 2018

Canadian cannabis producer Aphria to buy Nuuvera for $826 mln

Jan 29 Canadian cannabis producer Aphria Inc said on Monday it would buy rival Nuuvera Inc for $826 million to expand into Europe, Africa and the Middle East.

29 Jan 2018

Earnings vs. Estimates